Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress.
about
Genome-scale reconstruction of the metabolic network in Staphylococcus aureus N315: an initial draft to the two-dimensional annotation.Novel applications of COX-2 inhibitors, metformin, and statins for the primary chemoprevention of breast cancerOngoing clinical trials of the pleiotropic effects of statinsAcute treatment with rosuvastatin protects insulin resistant (C57BL/6J ob/ob) mice against transient cerebral ischemia.Antioxidant effects of statins in patients with atherosclerotic cerebrovascular disease.Therapeutic angiogenesis in diabetes and hypercholesterolemia: influence of oxidative stress.Treatment with pravastatin and fenofibrate improves atherogenic lipid profiles but not inflammatory markers in ACTG 5087Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapyTherapeutic levels of the hydroxmethylglutaryl-coenzyme A reductase inhibitor lovastatin activate ras signaling via phospholipase D2.Cardiovascular and inflammatory effects of simvastatin therapy in patients with COPD: a randomized controlled trialHMG-CoA reductase inhibitors enhance phagocytosis by upregulating ATP-binding cassette transporter A7.Pravastatin reverses obesity-induced dysfunction of induced pluripotent stem cell-derived endothelial cells via a nitric oxide-dependent mechanism.Microvascular responsiveness in obesity: implications for therapeutic intervention.Reactive oxygen and nitrogen species in pathogenesis of vascular complications of diabetes.Pleiotropic effects of calcium channel blockers.Euphol from Euphorbia tirucalli Negatively Modulates TGF-β Responsiveness via TGF-β Receptor Segregation inside Membrane Rafts.Chemoprevention of hormone receptor-negative breast cancer: new approaches neededAssessment of endothelial function: comparison of the pulse wave response to beta 2-adrenoceptor stimulation with flow mediated dilatationATP-binding cassette transporter G1 and high-density lipoprotein promote endothelial NO synthesis through a decrease in the interaction of caveolin-1 and endothelial NO synthase.Perioperative use of statins in noncardiac surgery.Attenuation by statins of membrane raft-redox signaling in coronary arterial endothelium.Eicosapentaenoic Acid Inhibits Oxidation of ApoB-containing Lipoprotein Particles of Different Size In Vitro When Administered Alone or in Combination With Atorvastatin Active Metabolite Compared With Other Triglyceride-lowering Agents.Enhancement of autophagy by simvastatin through inhibition of Rac1-mTOR signaling pathway in coronary arterial myocytes.Amelioration of cisplatin-induced nephrotoxicity by statins.Sphingosine-1-phosphate and modulation of vascular toneHMG CoA reductase inhibitors and renoprotection: the weight of the evidence.Comparison of Effects of Different Statins on Contrast-Induced Acute Kidney Injury in Rats: Histopathological and Biochemical Findings.The role of mitochondria in statin-induced myopathy.Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy.Oxidative Stress and Acute Kidney Injury in Critical Illness: Pathophysiologic Mechanisms-Biomarkers-Interventions, and Future Perspectives.Reduced membrane cholesterol after chronic hypoxia limits Orai1-mediated pulmonary endothelial Ca2+ entry.The Combination of Elevated Triglycerides and Abnormal Fasting Glucose Increases Risk of Cerebral Infarction in Patients With Mild to Moderate Hypercholesterolemia: A Post Hoc Analysis of the MEGA Study.Statins prevent tissue factor induction by protease-activated receptors 1 and 2 in human umbilical vein endothelial cells in vitro
P2860
Q24794109-AC691BFE-6902-4D4E-9CDC-AAD3A42F78A4Q28066348-939D1A27-1DFC-4888-9498-42A6ED410FEEQ28219321-0BA7B5D1-E4F0-49A4-A81F-E5A764FD024CQ33355932-E26A676C-FD66-4563-8F32-FDED5D4473B4Q33594766-8CB8A8B8-1A09-41D0-B176-3B5DFDF20345Q33765479-F35AE1BD-2F19-4EF7-8C4B-7C4126748F74Q34099851-5C6B0919-89B3-46FA-938A-9BBD74D2FD2CQ34429244-9543D9C7-2822-444E-A6DF-7EC4DB0ECB22Q34742771-1283D118-6323-45CD-BD11-FBF51CDAC446Q35063739-4A7FF6C1-5526-4805-BE6B-E020E7F62F07Q35147266-7C7C3D58-76B0-4763-94A4-FBD99E3D4260Q35237250-DAF79F0B-3CAD-4F21-8715-27CAEA8BB6C8Q35859728-01AE278A-9435-49AC-936B-5EC5952C407EQ36049201-A39289CE-8D0D-4FF6-B104-25B387BE77DEQ36072052-3389520D-9DDA-4127-B17D-460BB85E7344Q36137054-558098B1-7E06-4010-9989-634B4612789DQ36153371-B16E09F6-81DE-4FB7-800F-035EA6BA61B2Q36535895-40F47668-D65D-482E-A177-39BE0371F037Q36682924-BA2412DE-B211-4F6C-874E-CA69BBCC960DQ36766937-F8F51E52-0D43-42F2-9FB9-177DDE58F863Q36776589-8CAB64CA-9F6E-4854-B35B-B96169AB98C6Q37074239-0611739D-AFDD-42CE-9674-E244496ACD89Q37120403-CF778943-B93A-4673-9332-846B19C283F3Q37133302-1D47339C-254D-48F2-B612-2325F58E4A31Q37171310-658C505D-33E4-403C-8FA5-8187FB907814Q37362681-8233A928-2DBB-481E-A569-B2DDA76D6336Q37627553-784CA93B-2547-4C2B-AC7C-E17A35DBD7C1Q38492567-25457B22-1E50-4F27-AD94-05865CF26F49Q39514476-534A3DB8-2F46-4D5E-A892-CE18865FB47FQ46776795-43540F21-63EE-44A8-9AD9-A454E6BD45BBQ48367186-4435E394-7F1C-49C1-96AF-B4BDD3BE0BCEQ51321256-BCA3F1DC-FF6E-4711-AE51-CBADC3AA98D8Q57398738-4BE4A4F3-AEB8-4966-9E6C-548DA365EF82
P2860
Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Effects of HMG-CoA reductase i ...... odomains and oxidative stress.
@ast
Effects of HMG-CoA reductase i ...... odomains and oxidative stress.
@en
type
label
Effects of HMG-CoA reductase i ...... odomains and oxidative stress.
@ast
Effects of HMG-CoA reductase i ...... odomains and oxidative stress.
@en
prefLabel
Effects of HMG-CoA reductase i ...... odomains and oxidative stress.
@ast
Effects of HMG-CoA reductase i ...... odomains and oxidative stress.
@en
P2093
P1433
P1476
Effects of HMG-CoA reductase i ...... odomains and oxidative stress.
@en
P2093
Mary F Walter
R Preston Mason
Robert F Jacob
P304
P356
10.1161/01.CIR.0000129503.62747.03
P407
P433
21 Suppl 1
P577
2004-06-01T00:00:00Z